Transcatheter closure of perimembranous heart defects across centers
Official title: An International Multicenter Study on Transcatheter Device Closure of Perimembranous Ventricular Septal Defects
Run by Fondation Hôpital Saint-Joseph · NCT06823635 · Data updated 2026-11-12
This registry tests how well transcatheter closure devices work for perimembranous ventricular septal defects in kids and adults across several international centers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Month and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Fondation Hôpital Saint-Joseph Academic / other |
| Locations | 25 sites (Copenhagen and 24 other locations) |
| Status | Recruiting |
| Started | January 1, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | June 30, 2027 |
| Registry record updated | September 8, 2026 |
| Trial ID | NCT06823635 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with PmVSD measuring 3 to less than 20 mm on the LV side, age 1 month or older, weight 5 kg or more, and a left-to-right shunt who undergo transcatheter closure with any commercially available occluder device.
✕Probably not a fit
Patients with significant comorbidities, inability to attend follow-up, or refusal to share data may not benefit from the information gained.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an international, multicenter, observational registry that collects real-world data on outcomes after transcatheter closure of perimembranous ventricular septal defects (PmVSD). It is non-randomized and retrospective, aiming to assess feasibility, safety, and effectiveness of commercially available occluders, including off-label devices. Data are gathered from multiple sites with follow-up per local protocols to understand procedural success and device performance in a broad patient population. The study includes patients aged 1 month and older with 3–<20 mm defects on the left ventricular side and a left-to-right shunt, who underwent transcatheter closure with any occluder device. No control group is specified, and follow-up adherence is required for eligibility.
Why it matters
Potential benefit: If successful, the registry could clarify which devices provide favorable outcomes for PmVSD closure and inform clinical decisions across diverse patient groups.
How similar studies have gone: Previous reports have demonstrated feasibility and safety signals for transcatheter closures in various VSD contexts; this study aggregates broader international real-world data for PmVSD.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with perimembranous ventricular septal defects (PmVSD) diagnosed by 2D transthoracic echocardiography according to established classification systems, who provided informed consent and underwent transcatheter closure using any commercially available occluder devices (whether specifically designed for this indication or used off-label), with follow-up according to local hospital protocols. 2. Defect size between 3 mm and \<20 mm on the left ventricular side, as measured by 2D echocardiography. 3. Age ≥1 month and body weight ≥5 kg. 4. Left-to-right ventricular shunt. Exclusion Criteria: 1. Patients or legal guardians refusing the use of personal data for research purposes. 2. Failure to attend any follow-up visit post-discharge.
Where it's running
-
Copenhagen University Hospital, Rigshospitalet
Copenhagen, Denmark Recruiting -
Magdi Yacoub Heart Foundation
Cairo, Egypt Recruiting -
Marie Lannelongue Hospital
Le Plessis-Robinson, France Recruiting -
Lille University Hospital
Lille, France Recruiting -
Toulouse University Hospital
Toulouse, France Recruiting -
University Children's Hospital
Tübingen, Germany Recruiting
Show 19 more locations
-
Queen Mary Hospital
Hong Kong, Hong Kong Recruiting -
Hong Kong Children's Hospital
Kowloon Bay, Hong Kong Recruiting -
National Cardiovascular Center of Harapan Kita
Jakarta, Indonesia Recruiting -
Rajaie Cardiovascular, Medical and Research Center
Tehran, Iran Recruiting -
Hôtel-Dieu de France University Medical Center
Beirut, Lebanon Recruiting -
Hospital de Especialidades Pediátricas
Chiapas, Mexico Recruiting -
Silesian Center for Heart Diseases
Zabrze, Poland Recruiting -
Madinah Cardiac Center MC
Madinah, Saudi Arabia Recruiting -
Skane University Hospital
Skåne, Sweden Recruiting -
University Children's Hospital of Zurich
Zurich, Switzerland Recruiting -
Queen Sirikit National Institute of Child Health
Nonthaburi, Thailand Recruiting -
Prince of Songkla University
Songkhla, Thailand Recruiting -
Ankara City Hospital
Ankara, Turkey (Türkiye) Recruiting -
Koç University
Istanbul, Turkey (Türkiye) Recruiting -
Umraniye Training and Education Hospital
Istanbul, Turkey (Türkiye) Recruiting -
SBU Tepecik Training and Research Hospital
Izmir, Turkey (Türkiye) Recruiting -
Al Jalila Children's Speciality Hospital
Dubai, United Arab Emirates Recruiting -
University Hospital of Bordeaux
Bordeaux, France Enrolling by invitation -
The Children's Hospital
Lahore, Pakistan Enrolling by invitation
Study contacts
- Principal investigator: Raymond N. Haddad, MD, MHSc, PhDc — Marie Lannelongue Hospital, INSERM, UMR-S1358, UP-Saclay
- Study coordinator: Raymond N. Haddad, MD, MHSc, PhDc
- Email: raymondhaddad@live.com
- Phone: +33140942800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How long to take two blood-thinning medicines after leg artery procedures in CLTI
This study tests whether a shorter course of dual antiplatelet therapy after below-the-knee artery revascularization helps people with chronic limb threatening ischemia.
-
Hypnosis to improve comfort during transoesophageal echocardiography
This trial will test whether conversational and brief hypnosis given by the cardiologist can make transoesophageal echocardiography easier and less uncomfortable for adults having the procedure with local anaesthetic.
-
Digital care-coordination support for family caregivers after an emergency-department discharge
This pilot tests whether the Monka digital app helps family caregivers of adults discharged from the emergency department reduce caregiver burden and improve post-discharge outcomes.
-
Music during nursing care to improve comfort after an acute stroke in the neurovascular ICU
We will see if playing music during nursing care helps adults hospitalized in the neurovascular ICU after an acute stroke feel more comfortable.
-
Contrast perfusion ultrasound to help diagnose heart attacks in patients with suspected NSTEMI
We will test whether contrast-enhanced myocardial perfusion ultrasound can identify heart attacks or alternative causes in adults hospitalized with suspected non‑ST‑elevation acute coronary syndrome who are planned for coronary angiography.
-
Obstructive sleep apnea in children and a narrow upper jaw.
This project will test whether children aged 6–16 who have a narrow upper jaw are more likely to have obstructive sleep apnea, using overnight sleep studies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.